Welcome to LookChem.com Sign In|Join Free

CAS

  • or

40230-96-4

Post Buying Request

40230-96-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

40230-96-4 Usage

Description

1-((Trimethylsilyl)ethynyl)-3-fluorobenzene, also known as TESF or TFEB, is a chemical compound with the molecular formula C10H11F. It is a versatile building block in the field of organic chemistry, known for its unique reactivity and ability to undergo various chemical reactions.

Uses

Used in Pharmaceutical Industry:
1-((Trimethylsilyl)ethynyl)-3-fluorobenzene is used as a building block for the synthesis of various pharmaceuticals. Its unique reactivity allows for the creation of a wide range of compounds with potential therapeutic applications.
Used in Agrochemical Industry:
TESF is also utilized as a starting material for the development of new agrochemicals. Its ability to participate in various chemical reactions enables the synthesis of compounds with improved pesticidal or herbicidal properties.
Used in Materials Science:
In the field of materials science, 1-((Trimethylsilyl)ethynyl)-3-fluorobenzene is used as a precursor in the synthesis of fluorinated compounds. These compounds have applications in creating advanced materials with specific properties, such as improved stability or enhanced performance in various environments.
Used in Organic Chemistry Research:
TESF is a valuable compound in organic chemistry research due to its ability to undergo palladium-catalyzed cross-coupling reactions and Sonogashira coupling reactions. These reactions allow for the formation of complex molecular structures with potential applications in various industries.

Check Digit Verification of cas no

The CAS Registry Mumber 40230-96-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,2,3 and 0 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 40230-96:
(7*4)+(6*0)+(5*2)+(4*3)+(3*0)+(2*9)+(1*6)=74
74 % 10 = 4
So 40230-96-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H13FSi/c1-13(2,3)8-7-10-5-4-6-11(12)9-10/h4-6,9H,1-3H3

40230-96-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (563269)  1-[(Trimethylsilyl)ethynyl]-3-fluorobenzene  97%

  • 40230-96-4

  • 563269-5G

  • 401.31CNY

  • Detail

40230-96-4Relevant articles and documents

Stereoselective Synthesis of Methylene Oxindoles via Palladium(II)-Catalyzed Intramolecular Cross-Coupling of Carbamoyl Chlorides

Le, Christine M.,Sperger, Theresa,Fu, Rui,Hou, Xiao,Lim, Yong Hwan,Schoenebeck, Franziska,Lautens, Mark

supporting information, p. 14441 - 14448 (2016/11/13)

We report a highly robust, general and stereoselective method for the synthesis of 3-(chloromethylene)oxindoles from alkyne-tethered carbamoyl chlorides using PdCl2(PhCN)2 as the catalyst. The transformation involves a stereo- and regioselective chloropalladation of an internal alkyne to generate a nucleophilic vinyl PdII species, which then undergoes an intramolecular cross-coupling with a carbamoyl chloride. The reaction proceeds under mild conditions, is insensitive to the presence of moisture and air, and is readily scalable. The products obtained from this reaction are formed with >95:5 Z:E selectivity in nearly all cases and can be used to access biologically relevant oxindole cores. Through combined experimental and computational studies, we provide insight into stereo- and regioselectivity of the chloropalladation step, as well as the mechanism for the C-C bond forming process. Calculations provide support for a mechanism involving oxidative addition into the carbamoyl chloride bond to generate a high valent PdIV species, which then undergoes facile C-C reductive elimination to form the final product. Overall, the transformation constitutes a formal PdII-catalyzed intramolecular alkyne chlorocarbamoylation reaction.

NHC catalysed trimethylsilylation of terminal alkynes and indoles with Ruppert's reagent under solvent free conditions

Arde, Panjab,Reddy, Virsinha,Anand, Ramasamy Vijaya

, p. 49775 - 49779 (2014/12/11)

An organo-catalytic protocol for the trimethylsilylation of terminal alkynes employing Ruppert's reagent (CF3SiMe3) as a trimethylsilyl source has been developed under solvent and fluoride free conditions. This method was found to be very effective as a variety of terminal alkynes bearing aliphatic or aromatic substituents underwent smooth transformation to their corresponding silylated products in excellent yields within a few minutes using N-heterocyclic carbene as an organo-catalyst. This methodology was also applied to the chemospecific N-silylation of indoles. This journal is

Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform

Desai, Bimbisar,Dixon, Karen,Farrant, Elizabeth,Feng, Qixing,Gibson, Karl R.,Van Hoorn, Willem P.,Mills, James,Morgan, Trevor,Parry, David M.,Ramjee, Manoj K.,Selway, Christopher N.,Tarver, Gary J.,Whitlock, Gavin,Wright, Adrian G.

supporting information, p. 3033 - 3047 (2013/05/22)

Drug discovery faces economic and scientific imperatives to deliver lead molecules rapidly and efficiently. Using traditional paradigms the molecular design, synthesis, and screening loops enforce a significant time delay leading to inefficient use of data in the iterative molecular design process. Here, we report the application of a flow technology platform integrating the key elements of structure-activity relationship (SAR) generation to the discovery of novel Abl kinase inhibitors. The platform utilizes flow chemistry for rapid in-line synthesis, automated purification, and analysis coupled with bioassay. The combination of activity prediction using Random-Forest regression with chemical space sampling algorithms allows the construction of an activity model that refines itself after every iteration of synthesis and biological result. Within just 21 compounds, the automated process identified a novel template and hinge binding motif with pIC50 > 8 against Abl kinase - both wild type and clinically relevant mutants. Integrated microfluidic synthesis and screening coupled with machine learning design have the potential to greatly reduce the time and cost of drug discovery within the hit-to-lead and lead optimization phases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 40230-96-4